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Abstract: The EQ-5D-5L is a widely used generic instrument to measure health-related quality of life.
This study evaluates health perception in a representative sample of the general German population
from 2015. To compare results over time, a component analysis technique was used that separates
changes in the description and valuation of health states. The whole sample and also subgroups,
stratified by sociodemographic parameters as well as disease affliction, were analyzed. In total, 2040
questionnaires (48.4% male, mean age 47.3 year) were included. The dimension with the lowest
number of reported problems was self-care (93.0% without problems), and the dimension with the
highest proportion of impairment was pain/discomfort (71.2% without problems). Some 64.3% of
the study population were identified as problem-free. The visual analog scale (VAS) mean for all
participants was 85.1. Low education was connected with significantly lower VAS scores, but the
effect was small. Depression, heart disease, and diabetes had a strong significant negative effect
on reported VAS means. Results were slightly better than those in a similar 2012 survey; the most
important driver was the increase in the share of the study population that reported to be problem-free.
In international comparisons, health perception of the general German population is relatively high
and, compared with previous German studies, fairly stable over recent years. Elderly and sick people
continue to report significant reductions in perceived health states.
Keywords: health-related quality of life; EQ-5D-5L; population survey; Germany; 2015
1. Introduction
One key goal of health care provision is to improve health-related quality of life (HRQoL) [1].
HRQoL describes a multidimensional construct that includes physical, mental, functional, and social
factors determining quality of life [2]. In recent years, HRQoL has gained considerable importance in
the assessment of health care interventions. Furthermore, HRQoL is considered to be a fundamental
measure of population health [2–4]. In an aging society, with increasing prevalence of chronic diseases,
collecting mortality and morbidity data is no longer sufficient to assess the health impact of disease [5].
Therefore, instruments are used to measure HRQoL at the population level. One widely used and
validated instrument is the EuroQol five-dimension (EQ-5D) questionnaire [6–10]. The EQ-5D-5L is
currently available in 171 languages and has been used to measure HRQoL in population surveys
from various countries including the USA, Canada, the UK, and Germany [11–15]. In a nationwide
survey from Germany in 2015, the EQ-5D-5L questionnaire was also used to measure the HRQoL of
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a representative sample of the general German population. The aim of this study is to complement
previous population studies by analyzing the latest results on general health perception in Germany.
Focusing on the impact of age, sex, socioeconomic variables, and chronic disease, this evaluation
allows the identification of possible health trends and enables comparisons of health perception across
countries. Results of this study can serve as evidence for policy makers and as an up-to-date general
population reference for comparison of clinical populations.
2. Materials and Methods
Our dataset is based on an annual survey of the general German population conducted by the
IFAK research institute [16–19] on behalf of Wort & Bild Verlag (W&B). The survey’s goal is to gather
information regarding trends in health care, but the survey also includes questions on the health status
of the German population. Selected participants have to be part of the German population and at least
14 years of age. Personal interviews for this survey were conducted from September to October 2015.
The EQ-5D-5L questionnaire was completed in written form by participants themselves. To retrieve a
representative sample of the population, the W&B survey used a random-route procedure based on
516 sample points, structured by a specific BIK code (named after BIK Aschpurwis + Behrens GmbH,
Hamburg, Germany), a demographic and geographic classification system that has also been used in
past surveys. More details on the sampling system can be found elsewhere [16].
2.1. EQ-5D-5L
The EQ-5D-5L is a generic instrument measuring HRQoL and consists of two parts: first,
a descriptive system and, second, a visual analog scale (VAS). The descriptive system includes five
dimensions (mobility, self-care, usual activity, pain/discomfort, anxiety/depression) to describe the
health status of survey subjects. The VAS is used to assess general health and is a continuous response
scale ranging from 0 to 100, where 0 describes the worst and 100 the best possible condition [6,20].
Every dimension of the EQ-5D-5L includes five answer levels, covering no problems (1) to extreme
problems (5). Based on this, the descriptive score “11111” represents the best, problem-free health state
and “55555” the worst. The EQ-5D-5L is an updated version of the EQ-5D-3L questionnaire which
includes only three answer levels for each dimension. Advantages of the EQ-5D-5L, compared with
the EQ-5D-3L, include a greater variety of reported health states whereby, inter alia, ceiling effects are
reduced when used in a general population survey [11]. Psychometric properties of the EQ-5D-3L and
-5L have been evaluated across different diseases [8,21–23], and the questionnaire is used by a wide
variety of well-respected institutions including the NHS [24].
2.2. Data Analysis
All data analysis was conducted independently with SAS 9.3 (SAS Institute Inc., Cary, NC, USA)
and R 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria) by two different researchers.
Because of the annual assessment of health perception by the W&B survey and the lack of any major
health-related event in Germany, we expected that health perception would remain quite stable
compared with the previous three years. Demographic and socioeconomic variables such as education,
income, and occupation [25] have been found to influence quality of life measured by EQ-5D-3L
in the general population [26–28]. Accounting for these important determinants in the analysis of
this EQ-5D-5L survey, our study will evaluate the influence of the variables age (classified by age
groups), sex, educational background (“low”: in education, high school with/without apprenticeship;
“medium”: middle school; “high”: grammar school with/without university attendance), occupation,
and information about chronic diseases. To evaluate chronic diseases, participants were asked to
select up to six different diseases they currently are affected by, from a list. Considering distributional
assumptions, a linear model and the maximum likelihood estimation were used to examine the
impact of different parameters on VAS means. To account for patient heterogeneity, we refrained from
using value sets [29] and focused on VAS scores reported by respondents. To evaluate the stability
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of observed health states, we employed a component analysis developed by Kitagawa in 1955 [30].
The component analysis includes both the change in health state composition (=the share of people in
each health state) as well as changes in valuation for each health state (e.g., how VAS means change for
each group and year). We compared data from this survey with survey data from 2012, the first year in
which the EQ-5D-5L was used in W&B surveys. Comparison was restricted to health states reported
by at least five respondents in each sample. The difference in VAS means from 2015 and 2012 is split
into a case-mix component as well as a valuation component and interaction term (Equation (1)).
Equation (1). Component analysis for EQ-5D-5L health valuation based on Kitagawa (1955) [30]
VASA −VASB = ∑i VASBi (pAi − pBi)
+∑i pBi (VASpAi −VASpBi) + (pAi − pBi)(VASpAi −VASpBi)
p = % in each health state
i = health state
A, B = group year A, year B
∑ = sum over all groups i
3. Results
3.1. Characteristics of the Study Population
The total survey response rate was high and reached 71.8%. The most frequent reason for
non-response was absence of household members in 261 cases. A total of 2055 participants attended
the survey, but only 2040 questionnaires could be evaluated because 15 participants had missing health
perception data. Overall, more women participated in the survey. The average age was approximately
47 years. More than 60% of participants had medium or high education. The majority were employed
full-time or part-time (Table 1).
Table 1. Sample characteristics.
Characteristics n %
Sex male 987 48.38
female 1053 51.62
Mean age (years) total: 47.32 (±18.17)
males: 46.77 (±18.08)
females: 47.84 (±18.24)
Age groups (years) <19 151 7.40
20–29 272 13.33
30–39 305 14.95
40–49 395 19.36
50–59 327 16.03
60–69 288 14.12
70–79 249 12.21
80+ 53 2.60
Education * low 822 40.29
medium 785 38.48
high 433 21.23
Occupation full-time 1012 49.61
part-time 253 12.40
leave (parental leave, military/civil service) 12 0.59
unemployed 53 2.60
pension 452 22.16
housewife 70 3.43
undergoing training 96 4.71
no information 92 4.51
* Low education: in education, high school with/without apprenticeship; medium education: middle school; high
education: grammar school with/without university attendance.
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3.2. Descriptive System
Among the five dimensions, the fewest problems were reported for self-care (7.0%) and the most
for pain/discomfort (28.8%), followed by mobility (18.3%). Severe problems in any dimension were
very rare (1.4%). A majority of 64.3% were reported to be problem-free (11111).
3.3. VAS
In accordance with the descriptive system, VAS means were mostly within the upper range of the
scale. The VAS mean for all participants was 85.1.
3.3.1. Age and Sex
Men had a slightly higher VAS mean than women (86.4 vs. 83.9), whereas on average, women
were more than 1 year older than men. The marginally higher VAS mean for men was also observed
across age groups (Figure 1). Only in age group 70–79 years did women have a higher VAS mean than
men (71.7 vs. 70.8). Overall, the VAS means decreased with age (Figures 1 and 2).
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Figure 1. VAS means stratified by age group and sex.
The VAS means also varied depending on whether there were problems reported in the individual
dimensions or not. The VAS mean for participants in the problem-free health state (11111) was 92.3.
For participants with at least one reported problem, the VAS mean was 20 points less. The VAS
distribution by health status and age is illustrated in Figure 2. From age group 60–69 years onwards,
the share of participants with at least one problem was greater than the share of people who reported
to be problem-free (Figure 3).
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Figure 3. Sample share stratified by age group and health status.
Overall, the VAS m an of the 70- to 79-year-old p rticipants wa 25 oints belo t e VAS mean
of the 14- t 19-year-old participant . This tend ncy w also obs rved f r participants with t least
one problem. Only the mean VAS score for those younger than 19 years (n = 12) was markedly lower.
From age group 70–79 years to 80+ years, a big decrease in VAS means of around 10 points was
reported. Furthermore, the percentage of the study population without any health restrictions became
smaller with increasing age. Although 92.1% of age group 14–19 years were problem-free, only 7.6% of
age group 80+ years reported no problems.
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3.3.2. Education
VAS means increased with higher educational background but variance was high (Figure 4).
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3.3.3. Chronic Diseases
The most often stated chronic diseases were musculoskeletal disorders (n = 143), hypertension
(n = 141), and diabetes (n = 65). Table 2 shows the results of the multivariate linear model evaluating
the impact of sex, age, educational background, and disease affliction on VAS score. The density plot
of the models’ residuals was hardly skewed (not reported here), so no transformation was pursued
considering parameter interpretation. Although female sex and low educational background were
associated with slight deductions, depression and heart disease had a strong and significant negative
impact. Diabetes and arthrosis were also related to substantial deductions, whereas thyroid disease
and medium educational background had no significant impact.
Table 2. Linear model results, VAS as dependent variable.
Coefficient Estimator SE Pr (>|t|)
(Intercept) 107.15 1.09 ***
Sex (female) –1.56 0.54 **
Age –0.33 0.02 ***
Low education –2.27 0.73 **
Medium education 0.50 0.71
High education Reference
Depression –17.57 2.55 ***
Hypertension –7.48 1.13 ***
Migraine –5.62 2.21 *
Diabetes –12.45 1.56 ***
Musculoskeletal
disorders –8.95 1.09 ***
Thyro d disease –2.78 2.14
Heart disease –14.51 1.92 ***
Gastrointestinal diseases –4.20 2.02 *
Rheumatism –8.76 2.39 ***
Arthrosis –9.90 1.95 ***
SE: Standard error; Level of significance: * p < 0.05, ** p < 0.01, *** p < 0.001.
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3.4. Component Analysis
A total of 24 health states were observed by five or more respondents in both samples, covering
89.2% of the 2012 as well as the 2015 respondents. With a VAS mean of 88.1 in 2015 and 86.3 in
2012, a slight increase in VAS mean was observed by 1.8 on the 100 VAS scale. This is far below any
minimal clinical relevance. Decomposition of overall change shows that the case-mix component,
i.e., contributions from different health states reported, was 0.7 on the 100 VAS scale. The valuation
component reached 1.1 on the 100 VAS scale, whereas the interaction term was at 0.1. Details of
valuation changes vs. changes in shares observed show a 5.4% increase in the problem-free health state
(11111) but small valuation change (Figure 5), but only referring to about two thirds of the respondents
in the 2012 subsample analyzed here. Other health states make only minor contributions. Taken
together, a marginal but clinically non-relevant increase was observed; thus, health state valuation
remained quite stable.
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4. Discussion
Evaluating the health status of a representative sample of the general German population from
2015 leads to several important results. The majority of participants reported no limitations in the five
dimensions of the EQ-5D-5L. Women reported slightly lower HRQoL than men. A stronger negative
association was seen for low education compared with high education. Furthermore, as expected,
HRQoL deteriorates with increasing age. Extreme limitations were only rarely reported. Specific
chronic diseases have a strong and significant negative impact on general health status.
4.1. Age
VAS means decrease significantly with age. This might indicate an increase in disease-related
restrictions as people get older. Hinz et al. [13] observed an almost linear decrease in HRQoL, measur
by sum score, with increasing age. This is in line with pr vious studies in which HRQoL was measured
by EQ-5D [13,31,32] or other measuring instrument [13,33–35]. T e big decrease in VAS mean from age
group 70–79 years to 80+ years for participants without any restriction might result from health-related
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problems that are not covered by the five dimensions. However, the small sample size (age 80 + years,
n = 4) may also be a reason for distortions in this age group.
4.2. Sex
Men had higher VAS means than women in every age group except 70–79 years. The international
overview by Szende et al. [32] displays similar results using the EQ-5D-3L, and a number of other studies
indicate this gender-specific trend irrespective of the measurement method [11,27,36–38]. Interestingly,
we observed the same trend reversal for age group 70–79 years as did McCaffrey et al., 2016 [39]. In both
studies, these were the only age groups in which women reported better health perception than men.
In general, the differences between the genders are comparatively moderate and far below the limits
that are considered as minimal clinically important differences [40].
4.3. Education
The linear model shows a significant negative impact of low education on VAS means. This is
also observed in previous studies [17,41–43]. Education cannot explain all valuation change but, if the
educational distribution of a similar study from 2006 [18], in which the proportion of participants
with low education was 7.3 percentage points higher than in this study, were to be applied to the
explanatory VAS model in this study, the VAS mean for the entire study population would be slightly
lower at 84.7 (vs. 79.2 in 2006).
4.4. Chronic Diseases and VAS
Another negative association was found for chronic diseases and VAS means (Table 2).
In particular, depression, heart disease, and diabetes seem to have strong negative effects on HRQoL.
Golicki et al. [44] reported between 15.7 and 23.2 points lower VAS means for participants with
type 2 diabetes compared with the general population. A study from Korea [45] also shows a
decrease of 9.6 points for VAS means in people with coronary heart disease. Recent research from
China [46] regarding the HRQoL of mentally ill participants compared with older participants without
psychological disorders shows estimators of −10.7 for heart disease and −8.3 for mental illness.
These results underscore the outcomes of our study.
4.5. Comparison with Other Studies
The mean VAS score in this study is 85.1, the average age is 47.3 years, and the percentage of
female participants is 51.6%. A range of comparative studies exist using the EQ-5D-3L. However,
the descriptive system of the EQ-5D-3L is less differentiated than the 5L answer version. An earlier
study by W&B Verlag reported a VAS mean of 79.2 for a study population with 54.4% women and
an average age of 46.4 years in 2006 [18,19]. In addition to the increase in HRQoL since 2006 shown
in comparison with VAS values in this study, surveys by the Bertelsmann Gesundheitsmonitor [47]
indicate a considerable improvement in satisfaction with health care provision. In 2006, only 36% of
people with statutory health insurance were rather or very satisfied, compared with 61% in 2015.
The review by Szende et al. [32] enables international comparison. VAS means of 75.3 are reported
for Argentina and 83.7 for Denmark; the value for Germany is 77.3. It should be noted that the German
survey data [38] in this review date back to 2001/2003, and the average age (48.1 years) as well as the
percentage of women (51.8%) were slightly higher. A Swedish survey with 49,169 participants living in
mainly urban areas in Sweden reports a VAS mean of 79.5 [38]. The study dates back to 2004/2006, the
average age is 46.2 years, and 56.3% of participants were female. A study from France [48] reported a
VAS mean of 77.0 (average age 46.1 years; share of women 51.7%) but included 51.8% of participants
with low education (the term was not specified further).
Only a few comparative studies exist for the EQ-5D-5L as a measure of population health. One of
the first German EQ-5D-5L studies in 2011 [13] does not report any VAS values, as does a study from
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Poland [49]. This aggravates overall HRQoL assessment, as the five dimensions of the descriptive
system do not capture all aspects of disease equally well [50–52].
The VAS values in this study can also be compared with earlier and methodologically identical
studies from 2012, 2013, and 2014, which show relatively high VAS means (83.3; 84.9; 84.8) [16].
The comparison with 2012 data (Figure 5) revealed that health state valuation remained quite stable.
Only the share of people reporting no problems (=11111) increased by 5.4%. Further research has to
determine to what extent this difference and possible trends are based on sample heterogeneity.
There are four comparable international studies for the EQ-5D-5L. The study by
Garcia-Gordillo et al. [53] states a VAS mean of 75.7 (average age not available; share of women 54.1%)
in the general Spanish population. Feng et al. [11] report a VAS mean of 78.4 for England. The average
age was 51.6 years (author correspondence), which is 4 years higher than in this study. Moreover, the
percentage of women participating in the study was 59.3%. Another study with 4406 participants from
Alberta, Canada, reports a VAS mean of 79.0, despite a higher proportion of men (50.1%) and lower
average age (46.1 years) [54]. It is surprising that the VAS difference between the youngest age group
(18–29 years: 83) and the oldest age group (80+ years: 75) is merely 8 points. This is considerably lower
than the 30-point difference in our study. However, one distinctive difference between the Canadian
and this study is the selection procedure. The response rate of the Canadian telephone interviews was
only 31.7%. Strong self-selection cannot therefore be excluded. It is possible that sicker people with
lower HRQoL are more likely to participate in such surveys. McCaffrey et al. (2016) reported a mean
VAS score of 78.6 for a large community sample from South Australia [39]. The mean age in their study
was 46.3 years and 51.1% of participants were female. Despite these methodological differences, the
national as well as the international studies indicate a relatively high overall perception of HRQoL in
Germany that has been relatively consistent over recent years.
4.6. Limitations and Strength
One limitation of this study is the small sample size of participants with extreme problems and
the large number of people who were reported to be problem-free (61.5% vs. below 50% in most
other studies). It seems obvious that seriously ill people with low HRQoL are seldom found at home
because they are in hospital or unable to participate for other reasons. For the evaluation of EQ-5D-5L
health states with extreme problems, further studies based on adapted selection processes would be
useful. A weighting of data in accordance with census data has not taken place, but the deviation
from W&B data was small (<1% in the majority of age groups). One strength of this study lies in
the annual repetition of the W&B survey, the database for this study. The relatively similar database
enables good comparability of data across single years as long as the same version of the EQ-5D is
used. Furthermore, this study is one of the first studies to evaluate the EQ-5D-5L and especially the
VAS for measuring the health status of the general German population. The utilized random-route
procedure to select the study population ensures high representability of the database.
5. Conclusions
Compared with previous studies, the health perception of the general German population remains
relatively stable. A slight increase in VAS values was observed. Older people with specific diseases
perceive significant decreases in HRQoL, especially those affected by depression, heart disease,
or diabetes. Health perception of the general German population in 2015 is relatively high compared
with (mostly older) population surveys from other countries. Changes in population health can be
detailed using component analysis techniques.
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